drug
pegfilgrastim
Marketedupdated 6mo agoby Accord Biopharma Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval10 co-mentions · 5 sources
- drugSTIMUFEND8 co-mentions · 4 sources
- companyFresenius Kabi USA LLC4 co-mentions · 4 sources
- drugRNS-604 co-mentions · 4 sources
- companyAccord Biopharma Inc2 co-mentions · 1 sources
- tagRecall2 co-mentions · 1 sources
- drugARMLUPEG2 co-mentions · 1 sources
- companyLupin Ltd1 co-mentions · 1 sources
all catalysts(0)
nothing on the calendar yet
Trials studying pegfilgrastim
- phase2Molecularly Stratified Trial for Newly Diagnosed Infant-Type Hemispheric Glioma
- phase2Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma
- phase1Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.
- phase2FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer
- phase2ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
- phase2Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
- phase2Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
- phase2Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
News(1)
- Coherus cuts 30% of staffers, Gyre makes post-acquisition layoffsCoherus is narrowing its pipeline projects while Gyre reorganizes after an acquisition, with both biotechs conducting workforce reductions.biospace · 6d ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that